共 154 条
- [1] Abdallah OM(2018)Development and validation of LC‐MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human plasma: application to pharmacokinetic study Biomed Chromatogr 32 1094-undefined
- [2] Abdel-Megied AM(2018)Pharmacokinetic evaluation of daclatasvir and ledipasvir in healthy volunteers using a validated highly sensitive spectrofluorimetric method Luminescence 33 6-undefined
- [3] Gouda AS(2021)A green homogeneous liquid-liquid microextraction method for spectrophotometric determination of daclatasvir in human plasma Sustain Chem Pharm 22 57-undefined
- [4] Abdallah OM(2019)Molecularly imprinted polymer/reduced graphene oxide‒based carbon‒paste sensor for highly sensitive determination of the anti‒HCV drug daclatasvir dihydrochloride Sensors Actuators B Chem 283 1333-undefined
- [5] Abdel-Megied AM(2019)Micellar spectrofluorimetric protocol for the innovative determination of HCV antiviral (daclatasvir) with enhanced sensitivity: application to human plasma and stability study Spectrochim Acta Part A Mol Biomol Spectrosc 206 369-undefined
- [6] Gouda AS(2018)Two validated spectrofluorimeteric and high performance liquid chromatography (HPLC) methods with fluorescence detection for the analysis of a new anti-hepatitis C drug, daclatasvir hydrochloride, in raw material or tablet form and in biological fluids Luminescence 33 1118-undefined
- [7] Abdallah IA(2022)Dibenzo-18-crown-6-based carbon paste sensors for the nanomolar potentiometric determination of daclatasvir dihydrochloride: an anti-HCV drug and a potential candidate for treatment of SARS-CoV-2 Microchem J 177 1-undefined
- [8] Hammad SF(2016)A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma J Pharm Biomed Anal 125 194-undefined
- [9] Bedair A(2017)Electrochemical design of a new nanosensor based on cobalt nanoparticles, chitosan and MWCNT for the determination of daclatasvir: a hepatitis C antiviral drug RSC Adv 7 13-undefined
- [10] Mansour FR(2019)A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study J Chromatogr B 1120 24-undefined